Copertina

Structural bases for stoichiometry‐selective calcium potentiation of a neuronal nicotinic receptor

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Simone Mazzaferro, Guipeun Kang, Kathiresan Natarajan, Ryan E. Hibbs, Steven M. Sine
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2024
Soggetti:	British Journal of Pharmacology
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Pharmacological treatment with a GABA(A) receptor modulator and a selective serotonin reuptake inhibitor as a mitigation strategy against aircraft noise‐induced cardiovascular and neuronal damage
di: Ivana Kuntić, et al.
Pubblicazione: (2026)

Correction to “Hippocampal α7 nicotinic ACh receptors contribute to modulation of depression‐like behaviour in C57BL/6J mice”
Pubblicazione: (2025)

Chemistry/structural biology of psychedelic drugs and their receptor(s)
di: Ryan H. Gumpper, et al.
Pubblicazione: (2024)

Biphasic effect of nicotine on glutamatergic activity in male mouse brain
di: Prajakta Pramod Biyani, et al.
Pubblicazione: (2025)

A subtype‐selective photoswitchable agonist for precise manipulation of GABAA receptors
di: Simon Miguel M. Lopez, et al.
Pubblicazione: (2025)

The mitochondrial calcium uniporter inhibitor Ru265 increases neuronal excitability and reduces neurotransmission via off‐target effects
di: Peng Xu, et al.
Pubblicazione: (2024)

Cannabinoid CB2 receptor‐mediated analgesia: mechanism‐based insights and therapeutic potential
di: Kelsey G. Guenther, et al.
Pubblicazione: (2025)

The potential for biased signalling in the P2Y receptor family of GPCRs
di: Claudia M. Sisk, et al.
Pubblicazione: (2025)

Neuroprotective amyloid β N‐terminal peptides differentially alter human α7‐ and α7β2‐nicotinic acetylcholine (nACh) receptor single‐channel properties
di: Catherine F. Roberts, et al.
Pubblicazione: (2024)

Direct neuronal protection by the protease‐activated receptor PAR4 antagonist ML354 after experimental stroke in mice
di: Michael Fleischer, et al.
Pubblicazione: (2024)

P2X7 receptor‐dependent increase in endocannabinoid 2‐arachidonoyl glycerol production by neuronal cells in culture: Dynamics and mechanism
di: Simar Singh, et al.
Pubblicazione: (2024)

Sex differences in the vasoactive effect of transient receptor potential channels: TRPM3 as a new therapeutic target for (neuro)vascular disorders
di: Eduardo Rivera‐Mancilla, et al.
Pubblicazione: (2025)

P2X7 receptor antagonism suppresses epileptiform‐like activity in an inflammation‐primed human iPSC‐derived neuron model of drug‐resistant epilepsy
di: Jaideep Kesavan, et al.
Pubblicazione: (2025)

Altered desensitization and internalization patterns of rodent versus human glucose‐dependent insulinotropic polypeptide (GIP) receptors. An important drug discovery challenge
di: Lærke Smidt Gasbjerg, et al.
Pubblicazione: (2024)

A novel selective stabilizer of the ryanodine receptor 2 prevents stress‐induced ventricular arrhythmias without impairing cardiac function
di: Nagomi Kurebayashi, et al.
Pubblicazione: (2026)

Transient receptor potential ankyrin 1 channel modulates the abuse‐related mechanisms of methamphetamine through interaction with dopamine transporter
di: Kwang‐Hyun Hur, et al.
Pubblicazione: (2024)

Blockade of cannabinoid CB1 receptors potentiates the anti‐fibrotic effects mediated by SGLT2 inhibition in a mouse model of diabetic nephropathy
di: Océane Pointeau, et al.
Pubblicazione: (2025)

Pharmacology of PACAP and VIP receptors in the spinal cord highlights the importance of the PAC1 receptor
di: Zoe Tasma, et al.
Pubblicazione: (2024)

Relevance of G protein‐coupled receptor (GPCR) dynamics for receptor activation, signalling bias and allosteric modulation
di: Marta Lopez‐Balastegui, et al.
Pubblicazione: (2024)

Structure–activity relationship of the allosteric effects of ivermectin at human P2X4 and GABAA receptors
di: Jessica L. Meades, et al.
Pubblicazione: (2025)

Opioid receptors in cardiovascular function
di: Venkatesh Katari, et al.
Pubblicazione: (2025)

Multivalent antibody‐based conjugates as new tools for tailored modulation of G protein–coupled receptors
di: Shivani Sachdev, et al.
Pubblicazione: (2026)

Efficacy and safety of a selective partial agonist for nociception/orphanin‐FQ peptide (NOP) receptors in patients with insomnia disorder
di: Garth T. Whiteside, et al.
Pubblicazione: (2025)

Pharmacodynamics, pharmacokinetics and CYP3A4 interaction potential of the selective P2X3 receptor antagonist filapixant: A randomized multiple ascending‐dose study in healthy young men
di: Christian Friedrich, et al.
Pubblicazione: (2024)

The ion channel TRPM8 is a direct target of the immunosuppressant rapamycin in primary sensory neurons
di: José Miguel Arcas, et al.
Pubblicazione: (2024)

Expression of fibroblast growth factor receptor 1 correlates inversely with the efficacy of single‐agent fibroblast growth factor receptor‐specific inhibitors in pancreatic cancer
di: Qingxiang Lin, et al.
Pubblicazione: (2024)

A highly selective inhibitor of discoidin domain receptor‐1 (DDR1‐IN‐1) protects corneal epithelial cells from YAP/ACSL4‐mediated ferroptosis in dry eye
di: Yiqin Dai, et al.
Pubblicazione: (2024)

Oral paltusotine, a nonpeptide selective somatostatin receptor 2 agonist: Mass balance, absolute bioavailability and metabolism in healthy participants
di: Rosa Luo, et al.
Pubblicazione: (2025)

Comparative analysis of formyl peptide receptor 1 and formyl peptide receptor 2 reveals shared and preserved signalling profiles
di: Denise Pajonczyk, et al.
Pubblicazione: (2024)

Carvedilol inhibits neuronal hyperexcitability caused by epilepsy‐associated KCNT1 mutations
di: Chang Di, et al.
Pubblicazione: (2024)

The Concise Guide to PHARMACOLOGY 2025/26: Catalytic receptors
di: Stephen P. H. Alexander, et al.
Pubblicazione: (2025)

The Concise Guide to PHARMACOLOGY 2025/26: G protein‐coupled receptors
di: Stephen P. H. Alexander, et al.
Pubblicazione: (2025)

An orally available Cav2.2 calcium channel inhibitor for the treatment of neuropathic pain
di: Janine Kutzsche, et al.
Pubblicazione: (2024)

Efficacy in diet‐induced obese mice of the hepatotropic, peripheral cannabinoid 1 receptor inverse agonist TM38837
di: Martin E. Cooper, et al.
Pubblicazione: (2024)

Inhibition of sphingosine‐1‐phosphate receptor‐2 attenuates chronic gastritis via blocking nuclear translocation of S1P 2 receptors in epithelial cells
di: Ke‐Qin Li, et al.
Pubblicazione: (2025)

Interleukin‐1 receptor‐associated kinase 4 (IRAK4) is a critical regulator of inflammatory signalling through toll‐like receptors 4 and 7/8 in murine and human lungs
di: Ian Sayers, et al.
Pubblicazione: (2024)

Toll‐like receptor 4 mediates lipopolysaccharide‐induced emesis
di: Luping Liu, et al.
Pubblicazione: (2026)

Ayahuasca‐enhanced extinction of fear behaviour: Role of infralimbic cortex 5‐HT2A and 5‐HT1A receptors
di: Isabel Werle, et al.
Pubblicazione: (2024)

Ventral pallidum GABAergic and glutamatergic neurons modulate arousal during sevoflurane general anaesthesia in male mice
di: Bing‐Qian Fan, et al.
Pubblicazione: (2025)

Difluorinated thromboxane A2 reveals crosstalk between platelet activatory and inhibitory pathways by targeting both the TP and IP receptors
di: Megan F. Allen, et al.
Pubblicazione: (2024)